Target intelligence / Profile preview

Pathogenic Myelin-Reactive CD4+ T Helper Cell (None)

Target
None
Molecular classification
T lymphocyte, CD4+ T helper cell, Immune cell
01

Overview

Pathogenic myelin-reactive CD4+ T helper cells are a subset of immune cells that recognize and respond to components of myelin, the insulating sheath around nerve fibers in the central nervous system (CNS). These autoreactive T cells play a central role in the development and progression of autoimmune demyelinating diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). They become activated when they encounter myelin-derived antigens presented by antigen-presenting cells (APCs) via MHC class II molecules. Upon activation, they differentiate into various effector subsets—primarily Th1 and Th17—which secrete proinflammatory cytokines such as IFN-γ, IL-17, GM-CSF, and others. The inflammatory milieu created by these cytokines leads to recruitment of additional immune cells into the CNS, resulting in inflammation, demyelination, oligodendrocyte injury, and neurodegeneration.

Other names
Autoreactive CD4+ T cellMyelin-specific CD4+ T cellMS-associated CD4+ T cellEAE-associated CD4+ T cell
02

Mechanism of action

Targeting these pathogenic populations or their effector functions is a major focus for immunomodulatory therapies in MS. Strategies include blocking key cytokines like IL‑17 or GM‑CSF or modulating costimulatory pathways involved in their activation/differentiation.

03

Biological functions

Immune responseT cell activationCytokine productionCell-mediated cytotoxicityInflammationAntigen presentation (indirectly via APC interaction)
04

Disease associations

Multiple SclerosisExperimental Autoimmune EncephalomyelitisAutoimmune diseaseNeuroinflammationDemyelination
05

Safety considerations

Immunosuppression leading to increased risk of infectionPotential for off-target effects on other immune cellsRisk of exacerbating other autoimmune conditions
06

Interacting drugs

Fingolimod

4 more in the full profile.

07

Biomarkers

Increased frequency of memory CCR6+ CD4+ T cellsElevated levels of IL-17A, GM-CSF, and IFN-γ productionTh17 gene signaturesMBP-specific T cell reactivityPLP-specific T cell reactivityMOG-specific T cell reactivity

Beyond the preview

Go deeper on Pathogenic Myelin-Reactive CD4+ T Helper Cell (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic Myelin-Reactive CD4+ T Helper Cell (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call